chr11-68684930-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_015973.5(GAL):c.7C>T(p.Arg3Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,605,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. R3R) has been classified as Likely benign.
Frequency
Consequence
NM_015973.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GAL | NM_015973.5 | c.7C>T | p.Arg3Ter | stop_gained | 2/6 | ENST00000265643.4 | |
LOC107984343 | XR_001748281.1 | n.230+2911G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GAL | ENST00000265643.4 | c.7C>T | p.Arg3Ter | stop_gained | 2/6 | 1 | NM_015973.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000427 AC: 10AN: 234012Hom.: 0 AF XY: 0.0000468 AC XY: 6AN XY: 128080
GnomAD4 exome AF: 0.0000200 AC: 29AN: 1453362Hom.: 0 Cov.: 29 AF XY: 0.0000207 AC XY: 15AN XY: 723054
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74366
ClinVar
Submissions by phenotype
Familial temporal lobe epilepsy 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2018 | This sequence change creates a premature translational stop signal (p.Arg3*) in the GAL gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs578193461, ExAC 0.009%). This variant has not been reported in the literature in individuals with GAL-related disease. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in GAL cause disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at